You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API adapalene


✉ Email this page to a colleague

« Back to Dashboard


Detailed excipient profiles for adapalene

Excipient focus: 1-PROPANESULFONIC ACID, 2-METHYL-2-((1-OXO-2-PROPEN-1-YL)AMINO)-, SODIUM SALT

Excipient focus: ACRYLIC ACID/SODIUM ACRYLATE COPOLYMER

Excipient focus: ALCOHOL

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER TYPE A

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CARBOMER HOMOPOLYMER TYPE C

Excipient focus: CARBOXYPOLYMETHYLENE

Excipient focus: CYCLOMETHICONE

Excipient focus: DOCUSATE SODIUM

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: ISOHEXADECANE

Excipient focus: LIMONENE

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYL GLUCOSE SESQUISTEARATE

Excipient focus: METHYLPARABEN

Excipient focus: PEG-20 METHYL GLUCOSE SESQUISTEARATE

Excipient focus: PHENOXYETHANOL

Excipient focus: POLOXAMER 124

Excipient focus: POLOXAMER 182

Excipient focus: POLYETHYLENE GLYCOL 1500

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYSORBATE 80

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER

Excipient focus: SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SORBITAN MONOOLEATE

Excipient focus: SQUALANE

Excipient focus: SQUALENE

Excipient focus: STEARYL ALCOHOL

Excipient focus: TROLAMINE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links